1 report

OBINUTUZUMAB: A NEW CLASS OF ANTI-CD## MONOCLONAL ANTIBODY.

  • Epidemiology
  • Hospital
  • Monoclonal Antibody
  • Therapy
  • Anthera Pharmaceuticals, Inc.